Jacob P. Lalezari
Equibles does not estimate personal net worth.
Get an email with a short summary when CytoDyn Inc. publishes a filing, an earnings call transcript or a press release.
Get CYDY alertsAbout Jacob P. Lalezari
Jacob P. Lalezari is recorded as CEO at CytoDyn Inc. (CYDY) since January 26, 2024. CytoDyn Inc. reported in an 8-K filed November 21, 2023 that Jacob P. Lalezari was appointed interim CEO, effective November 17, 2023. The proxy statement of CytoDyn Inc. reports total compensation of $1,833,398 for Jacob P. Lalezari in fiscal 2026, including a base salary of $409,896. Disclosed compensation is on record for 2 fiscal years. CytoDyn Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytoDyn Inc. includes Dr. Jacob P. Lalezari (CEO), Jacob P. Lalezari, M.D. (CEO), Robert E. Hoffman (CEO and CFO) and 7 others.
“On November 17, 2023, CytoDyn Inc., a Delaware corporation (the "Company"), entered into an employment agreement with. Jacob P. Lalezari, M.D. (the "Employment Agreement"), under which he will be employed as the Company's interim CEO on an at-will basis, effective November 17, 2023.”
Affiliation history
-
Current
2024-01-26–present
Company network
Leadership on record at CytoDyn Inc.
- Dr. Jacob P. Lalezari CEO
- Jacob P. Lalezari, M.D. CEO
- Robert E. Hoffman CEO, CFO
- Tanya Durkee Urbach Chairman
- Mitchell Cohen CFO, Chief Accounting Officer
- Dr. Christopher P. Recknor, M.D. COO
- Arian Colachis General Counsel
- Alan P. Timmins Board Member
- Gordon A. Gardiner Board Member
- Jordon G. Naydenov Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | CytoDyn Inc. (CYDY) | Chief Executive Officer | $409,896 | $1,833,398 |
| 2025 | CytoDyn Inc. (CYDY) | Chief Executive Officer | $400,000 | $783,850 |